Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Deutsche Boerse AG  >  GlaxoSmithKline    GS7   GB0009252882

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo GlaxoSmithKline
Develops, manufactures and distributes vaccines and other pharmaceutical products

‘GlaxoSmithKline Plc is a global healthcare company which engages in developing, manufacturing, and marketing of pharmaceutical products including vaccines, over the counter medicines and health-related consumer products.

It operates through the following segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines and Consumer Healthcare.

The Pharmaceuticals business researches, develops and makes available medicines that treat a variety of serious and chronic diseases.

The Vaccines business produces pediatric and adult vaccines to prevent a range of infectious diseases including, hepatitis A and B, diphtheria, tetanus and whooping cough, measles, mumps and rubella, polio, typhoid, influenza and bacterial meningitis.

The Consumer Healthcare business markets a range of consumer health products based on scientific innovation.

The company was founded on December 6, 1999 and is headquartered in Brentford, United Kingdom.
Managers
NameAgeSinceTitle
Emma Walmsley-2010Chief Executive Officer & Executive Director
Philip Hampton532015Non-Executive Chairman
Simon Dingemans542011Chief Financial Officer & Executive Director
Patrick J. T. Vallance, MD-2006Executive Director, President-R&D
Roy Malcolm Anderson692007Independent Non-Executive Director
Judy Carol Lewent682011Independent Non-Executive Director
Lynn Laverty Elsenhans, MBA602012Independent Non-Executive Director
Urs Rohner582015Independent Non-Executive Director
Manvinder Singh Banga622015Senior Independent Non-Executive Director
Jesse Goodman, PhD652016Independent Non-Executive Director
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 5,371,061,656 4,858,367,596 90.5% 453,205,950 8.4% 90.5%
Shareholders
NameEquities%
BlackRock Investment Management (UK) Ltd. 137,165,476 2.79%
The Vanguard Group, Inc. 130,204,719 2.65%
Legal & General Investment Management Ltd. 117,378,617 2.39%
Norges Bank Investment Management 102,997,000 2.09%
BlackRock Advisors (UK) Ltd. 88,133,021 1.79%
Capital Research & Management Co. (Global Investors) 78,981,537 1.61%
State Street Global Advisors Ltd. 61,901,525 1.26%
Woodford Investment Management Ltd. 58,051,071 1.18%
Schroder Investment Management Ltd. 55,906,255 1.14%
BlackRock Fund Advisors 54,929,784 1.12%
Holdings
NameEquities%Valuation
Innoviva Inc (INVA) 32,005,26029.3%391,104,277 USD
Theravance Biopharma Inc (TBPH) 9,644,80718.1%352,035,456 USD
JCR Pharmaceuticals Co Ltd (4552) 7,986,00024.6%196,860,650 USD
Dong-A Socio Holdings Co Ltd (000640) 409,6936.67%57,816,626 USD
GlaxoSmithKline S.A.E. 76,161,37891.2%54,070,770 USD
Crispr Therapeutics AG (CRSP) 3,220,6278.00%43,864,940 USD
Glaxo Smithkline Consumer Nig PLC (GLAXOSM) 444,065,54137.1%23,983,980 USD
Oncomed Pharmaceuticals Inc (OMED) 2,607,5466.93%8,500,600 USD
Allergy Therapeutics plc (AGY) 10,118,0001.70%3,526,730 USD
SCYNEXIS Inc (SCYX) 545,0062.11%866,560 USD
Sector
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Pharmaceuticals - NEC
Advertisement
Sector Pharmaceuticals - NEC
1st jan.Capitalization (M$)
GLAXOSMITHKLINE6.80%106 833
JOHNSON & JOHNSON18.42%367 520
NOVARTIS12.96%225 386
ROCHE HOLDING LTD.8.68%224 497
PFIZER4.80%203 487
MERCK AND COMPANY11.98%180 958
SANOFI15.34%123 860
BAYER23.22%112 730
GLAXOSMITHKLINE9.54%106 833
BRISTOL-MYERS SQUIBB C..-2.60%93 311
ELI LILLY AND COMPANY14.59%92 560
NOVO NORDISK A/S15.43%86 701
ASTRAZENECA22.34%86 691
ABBOTT LABORATORIES27.34%85 167
ALLERGAN PLC17.36%82 778
SHIRE-3.53%52 013
TAKEDA PHARMACEUTICAL ..19.63%40 858
TEVA PHARMACEUTICAL IN..-16.92%32 234
ASTELLAS PHARMA INC-13.81%26 111
CHUGAI PHARMACEUTICAL ..26.97%21 041
MYLAN NV2.31%20 919
Sector Pharmaceuticals - NEC
GlaxoSmithKline : Connections
Genome Research Ltd.
UK Biobank Ltd.
Swiss Bankers Association
The Natural History Museum
Institute of Medicine
Lucerne Festival
French Academy of Sciences
European Financial Services Round Table
Pearson Education Ltd.
Kedaara Capital I Ltd.
National Theatre of Scotland
Institute International d'Etudes Bancaires
Smithkline Beecham Ltd.
Office for Strategic Co-ordination of Health Research
Rockefeller Family Trust, Inc.
New York State Bar Association
American Academy of Arts & Sciences
Massachusetts Institute of Technology
Diversey, Inc.
Sunoco Chemicals, Inc.
The Indus Entrepreneurs (Delhi)
Sunoco Partners LLC
The Institute of International Finance, Inc.
Avenir Suisse
Opernhaus Zürich AG
IMD Scholarship Foundation
Alfred Escher-Stiftung
United Way of Greater Houston
Economiesuisse
Rice University
International Institute for Management Development
World Golf Foundation, Inc.
Swiss Finance Council
The Texas Medical Center
Zurich Bar Association
Central Houston, Inc.
Mauser Group NV
The First Tee of Greater Houston
The Council for Industry & Higher Education
The United States Pharmacopeia
The 100 Group
Indian Institute of Management
Credit Suisse Americas Foundation
World Presidents' Organization
Zurich Chamber of Commerce
Indian School of Business
Credit Suisse AG
Georgetown University
Company contact information
980 Great West road
TW8 9GS Brentford, Greater London
United Kingdom

Phone : +44 (0)20 8047 5000
Fax : +44 (0)20 8047 7807
Internet : http://www.gsk.com
Markets and indexes
- London Stock Exchange, SETS
- Main Market
- FTSE 100 / FTSE 350, FTSE All-Share, FTSE Eurotop 100, Low Carbon 100 Europe, Stoxx Europe 50, Stoxx Global 200, Stoxx UK 50
Stock Exchange Codes
- ISIN Code :  GB0009252882
- Bloomberg Code :  GSK:LN
- Reuters Code :  GSK.L
- Datastream Code :  GSK
© 2017 People , Fundamentals and Ownership    © 2017 Cofisem